{{Rsnum
|rsid=1277203
|Gene=AKNAD1
|Chromosome=1
|position=108850215
|Orientation=plus
|GMAF=0.4036
|Gene_s=AKNAD1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 9.7 | 46.0 | 44.2
| HCB | 7.4 | 35.3 | 57.4
| JPT | 7.1 | 54.9 | 38.1
| YRI | 60.5 | 34.0 | 5.4
| ASW | 35.1 | 45.6 | 19.3
| CHB | 7.4 | 35.3 | 57.4
| CHD | 7.3 | 41.3 | 51.4
| GIH | 7.9 | 34.7 | 57.4
| LWK | 54.5 | 38.2 | 7.3
| MEX | 8.6 | 51.7 | 39.7
| MKK | 32.9 | 44.5 | 22.6
| TSI | 7.8 | 37.3 | 54.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=9E-6
  |OR=1.62
  |ORtxt=[1.243-2.098]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}